Mark Shamis
Current Student at Brandeis University and on the Brandeis Fencing team, aspiring to become a Biochemist, focused on creating and discovering medicines.
Welcome to Filtricine, Inc., we are a clinical stage biotech company. Filtricine is developing a proprietary targeted nutrients deprivation (TND) technology to help patients living with cancer manage their diseases. Our lead product is being tested in clinical studies. Contact us on our website if you are interested in knowing more.
